Issue 10, 2013

Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry

Abstract

Liquid chromatography-mass spectrometry (LC-MS) is an information rich analytical tool that can provide fast, robust and sensitive characterization of protein therapeutics for quality assurance and structural comparison. Herein, structural characterization of two anti-CD20 monoclonal antibodies obtained from two different sources was performed using a middle-down LC-MS strategy to determine if they can be analytically differentiated. Through the use of a specific enzymatic digestion method using IdeS with subsequent LC-MS analysis, we show that the anti-CD20 monoclonal antibody that has been approved by the FDA can be partially characterized and differentiated analytically from an Indian sourced product that lacks FDA approval. In comparison to the FDA-approved product, differential modifications to both the N- and C-termini result in increased charge heterogeneity for the Indian product. In addition, significant differences in the intensities of the observed glycoforms between the two antibodies were detected. While this study assesses only one lot of each of a FDA approved drug product and the Indian sourced drug product, the observed differences may represent process specific fingerprints that could be useful for surveillance purposes.

Graphical abstract: Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry

Article information

Article type
Paper
Submitted
19 Oct 2012
Accepted
29 Mar 2013
First published
03 Apr 2013

Analyst, 2013,138, 3058-3065

Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry

B. Wang, A. C. Gucinski, D. A. Keire, L. F. Buhse and M. T. Boyne II, Analyst, 2013, 138, 3058 DOI: 10.1039/C3AN36524G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements